Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Inspire Medical Systems, Inc.

NYSE: INSP · Industrial Applications and Services · 3 alerts · CIK 1609550

Share price
$59.12Close, Nov 16
Market cap
$1.71B
Shares outstanding
28.97MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Inspire Medical Systems, Inc. filings on SEC EDGAR ↗

4:32 PM ET 10-Q
Financial Results ▶ Call

Inspire Medical Systems Q3 2026 Results: Net Loss of $24.4M

For the nine months ended September 30, 2026, Inspire Medical Systems reported a net loss of $35.4 million on revenue of $611.9 million, compared to a net profit of $9.3 million in the prior year period. The shift to a loss was driven by a decrease in revenue and a significant increase in selling, general, and administrative expenses.

Key figure
Net loss $24.4M
4:30 PM ET 8-K
Financial Results

Inspire Medical Systems Financial Results

Inspire Medical Systems reported Q3 2026 revenue of $206.7 million, a 7.9% decrease year-over-year primarily due to U.S. coding and reimbursement challenges. Despite the revenue decline, the company achieved a positive adjusted diluted EPS of $0.14 and noted that the AMA approved new Category I CPT codes for its Inspire V system effective 2028.

Term
3 months

“We are pleased to have delivered sequential growth in the third quarter, with U.S. performance coming in ahead of our expectations. Results suggest that, despite some lingering headwinds, there is greater comfort among implanting physicians with the current coding dynamic.”

Tim Herbert, Chairman and CEO of Inspire Medical Systems

“Looking further ahead, we were also pleased with the AMA Editorial Panel’s September approval of a new CPT® code for single lead HGNS devices, including the Inspire V system. When this takes effect in January 2028, a dedicated code set will give physicians and hospitals enhanced clarity around coding and reimbursement and, in turn, further enable patient access to Inspire therapy.”

Tim Herbert, Chairman and CEO of Inspire Medical Systems

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.